Aktuelles

Shareholders’ general meeting of 16 april 2013

16. 04. 2013 - Finanzen

- Approval of all resolutions
- Dividend: final dividend payment of €1.22 per share in cash or new shares on 22 May 2013
- Renewal of the appointment of a director
- Nomination of two directors

VINCI’s Combined Shareholders’ General Meeting of 16 April 2013 approved all the resolutions submitted to it. The result of the shareholders’ votes will be available shortly on the Group’s website at www.vinci.com.

Under ordinary business, the Shareholders’ General Meeting also approved the consolidated and parent company financial statements for the year ended 31 December 2012 and decided to pay a dividend of €1.77 per share in respect of that year. Since an interim dividend of €0.55 per share was paid in November 2012, the final dividend will be €1.22, payable in cash or new shares at a price of €32.51 per share.

The ex-date for the final dividend payment is 23 April 2013. Payment of the final dividend in cash or new shares will take place on 22 May 2013.

Under ordinary business, the Shareholders’ General Meeting approved the renewal of the appointment of Mr Michael Pragnell as a director for a period of four years as well as the nomination of Mrs Yannick Assouad and Mrs Graziella Gavezotti to the board of directors for a period of four years. These nominations lift the percentage of women on VINCI’s board of directors from 15.4% to 30.8%.

Additional information:

Mr Michael Pragnell is a graduate of St John’s College, Oxford and INSEAD. In 1968, he joined Courtaulds Ltd where he held positions in marketing and sales. In 1974, he joined First National Bank of Chicago in the international department in New York. From 1975 to 1995, Mr Pragnell held various positions within the Courtaulds group: International Paint plc (1975–1985), Chief Executive Officer of National Plastics (1985–1986), Chief Executive Officer of International Paint plc (1986–1992) and Chief Financial Officer (1992–1994) of Courtaulds plc, where he was appointed to the Board of Directors in 1990. From 1995 to 2000, he was Chief Executive Officer of Zeneca Agrochemicals and a member of the Executive Committee of Zeneca plc (now known as AstraZeneca plc), and was appointed to its Board of Directors in 1997. From 1996 to 1999, he was Director of David S Smith plc and of Advanta BV (Netherlands). In 2000, Mr Pragnell was appointed as the founding Chief Executive Officer and Chairman of the Executive Committee of Syngenta AG, where he was also a founding member of the Board of Directors. From 2002 to 2005, he was Chairman of CropLife International. Mr Pragnell is currently Chairman of Cancer Research UK.

Mme Yannick Assouad is a graduate of the Institut National des Sciences Appliquées and the Illinois Institute of Technology. While working as an instructor at CIEFOP Paris, she joined Thomson CSF in 1986, where she was head of the thermal and mechanical analysis group until 1998. From 1998 to 2003, Ms Assouad served first as Technical Director and then as Chief Executive Officer of Honeywell Aerospace, before being appointed Chairman of Honeywell SECAN. In 2003, she joined Zodiac Aerospace, initially as Chief Executive Officer of Intertechnique Services, a post she held until 2008. Ms Assouad was then selected to create Zodiac Aerospace’s Services business segment, which she headed until 2010, when she was appointed Chief Executive Officer of the group’s Aircraft Systems segment.

Mme Graziella Gavezotti is a graduate of the Università di Comunicazione e Lingue (IULM) and has a degree in psychology from the University Rijeka (class of 1991). She worked for Jacques Borel Group, Gemeaz and Accor, before joining Edenred where she developed the Ticket Restaurant business in Italy. Since June 2012, she has been head of Edenred’s Southern Europe area, which includes Italy, Spain, Portugal, Turkey and Greece.